JPMorgan Chase & Co’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Buy |
712,100
+374,269
| +111% | +$3.47M | ﹤0.01% | 2500 |
|
|
2025
Q1 | $2.48M | Buy |
337,831
+148,536
| +78% | +$1.09M | ﹤0.01% | 3127 |
|
|
2024
Q4 | $1.62M | Buy |
189,295
+104,650
| +124% | +$894K | ﹤0.01% | 3526 |
|
|
2024
Q3 | $736K | Sell |
84,645
-728
| -0.9% | -$6.33K | ﹤0.01% | 3816 |
|
|
2024
Q2 | $584K | Buy |
85,373
+16,147
| +23% | +$110K | ﹤0.01% | 3787 |
|
|
2024
Q1 | $630K | Buy |
69,226
+1,201
| +2% | +$10.9K | ﹤0.01% | 3823 |
|
|
2023
Q4 | $303K | Buy |
68,025
+148
| +0.2% | +$660 | ﹤0.01% | 4176 |
|
|
2023
Q3 | $213K | Buy |
67,877
+3,766
| +6% | +$11.8K | ﹤0.01% | 4206 |
|
|
2023
Q2 | $331K | Buy |
64,111
+170
| +0.3% | +$877 | ﹤0.01% | 3987 |
|
|
2023
Q1 | $337K | Buy |
63,941
+17,838
| +39% | +$94K | ﹤0.01% | 4032 |
|
|
2022
Q4 | $130K | Sell |
46,103
-1,444
| -3% | -$4.07K | ﹤0.01% | 4389 |
|
|
2022
Q3 | $198K | Buy |
47,547
+3,320
| +8% | +$13.8K | ﹤0.01% | 4177 |
|
|
2022
Q2 | $178K | Sell |
44,227
-1,027
| -2% | -$4.13K | ﹤0.01% | 4377 |
|
|
2022
Q1 | $224K | Buy |
45,254
+8,439
| +23% | +$41.8K | ﹤0.01% | 4387 |
|
|
2021
Q4 | $257K | Buy |
36,815
+2,748
| +8% | +$19.2K | ﹤0.01% | 4409 |
|
|
2021
Q3 | $340K | Buy |
34,067
+868
| +3% | +$8.66K | ﹤0.01% | 4150 |
|
|
2021
Q2 | $471K | Sell |
33,199
-7,105
| -18% | -$101K | ﹤0.01% | 4030 |
|
|
2021
Q1 | $661K | Sell |
40,304
-41,576
| -51% | -$682K | ﹤0.01% | 3893 |
|
|
2020
Q4 | $1.7M | Sell |
81,880
-146,158
| -64% | -$3.03M | ﹤0.01% | 3067 |
|
|
2020
Q3 | $1.78M | Buy |
228,038
+210,794
| +1,222% | +$1.65M | ﹤0.01% | 2827 |
|
|
2020
Q2 | $144K | Buy |
17,244
+3,750
| +28% | +$31.3K | ﹤0.01% | 3812 |
|
|
2020
Q1 | $67K | Sell |
13,494
-99
| -0.7% | -$492 | ﹤0.01% | 4057 |
|
|
2019
Q4 | $54K | Hold |
13,593
| – | – | ﹤0.01% | 4215 |
|
|
2019
Q3 | $41K | Sell |
13,593
-279,354
| -95% | -$843K | ﹤0.01% | 4320 |
|
|
2019
Q2 | $1.3M | Buy |
292,947
+275,307
| +1,561% | +$1.22M | ﹤0.01% | 2920 |
|
|
2019
Q1 | $70K | Buy |
17,640
+9,110
| +107% | +$36.2K | ﹤0.01% | 4112 |
|
|
2018
Q4 | $34K | Sell |
8,530
-44,134
| -84% | -$176K | ﹤0.01% | 4376 |
|
|
2018
Q3 | $362K | Sell |
52,664
-22,848
| -30% | -$157K | ﹤0.01% | 3638 |
|
|
2018
Q2 | $509K | Buy |
75,512
+69,707
| +1,201% | +$470K | ﹤0.01% | 3441 |
|
|
2018
Q1 | $38K | Sell |
5,805
-21,022
| -78% | -$138K | ﹤0.01% | 4236 |
|
|
2017
Q4 | $119K | Sell |
26,827
-305,873
| -92% | -$1.36M | ﹤0.01% | 3836 |
|
|
2017
Q3 | $2.13M | Sell |
332,700
-5,800
| -2% | -$37.1K | ﹤0.01% | 2598 |
|
|
2017
Q2 | $3.14M | Sell |
338,500
-27,325
| -7% | -$253K | ﹤0.01% | 2386 |
|
|
2017
Q1 | $3.39M | Buy |
+365,825
| New | +$3.39M | ﹤0.01% | 2313 |
|